Skip to main content

Aneuploidy

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Ferring Pharmaceuticals
Ferring PharmaceuticalsArgentina - Buenos Aires
1 program
Coenzyme Q10 concomitant treatmentN/A1 trial
Active Trials
NCT01048385Terminated34Est. Dec 2012
Pediatrix Therapeutics
Pediatrix TherapeuticsChina - Shanghai
1 program
non-invasive prenatal testingN/A1 trial
Active Trials
NCT02284399Completed4,488Est. Dec 2016

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Pediatrix Therapeuticsnon-invasive prenatal testing
Ferring PharmaceuticalsCoenzyme Q10 concomitant treatment

Clinical Trials (2)

Total enrollment: 4,522 patients across 2 trials

NCT02284399Pediatrix Therapeuticsnon-invasive prenatal testing

National Prevalence and Impact of Noninvasive Prenatal Testing

Start: Jan 2014Est. completion: Dec 20164,488 patients
N/ACompleted
NCT01048385Ferring PharmaceuticalsCoenzyme Q10 concomitant treatment

The Effect of Co Enzyme Q10 Together With Fertility Drugs on Pregnancy Outcome of in Vitro Fertilization

Start: Dec 2009Est. completion: Dec 201234 patients
N/ATerminated

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.